Medical Device and Diagnostic Industry (MD+DI)

Next-Gen Sequencing Is Going Global, And 2026 Could Be the Tipping Point

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

$46.5 Bn Next Generation Sequencing Market Industry Trends and Global Forecasts to 2035 by Type of Component, NGS Technique, Technology, Application Area, Targ…

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
TMCnet

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention.
Miami University

Miami University acquires new third-generation DNA sequencing technology, first in Midwest

Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...
BioTechniques

The biotech bi-weekly: nucleic acid purification, metabolic heart failure research and AI-designed bispecific binding proteins

In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
GEN

The Best of NGS: Instrument Companies to Watch in 2025

The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
Hosted on MSN

Cyber Vulnerabilities in Next-Gen DNA Sequencing

Next-generation DNA sequencing (NGS)—the engine behind personalized medicine, cancer diagnostics, infectious disease tracking, and cutting-edge genetic research—is increasingly at risk of cyberattacks ...